Determination of Amino Acid Composition of Ganirelix Acetate in an Injectable Formulation by Pre-column Derivatization with 6-Aminoquinolyl-N-hydroxysuccinimidyl Carbamate

• Published in: Journal of chromatographic science 2020-08, Vol.58 (8), p.687-694
• Main Authors: Ummiti, Kumarswamy, Kumar, J V Shanmukha
• Format: Article
• Language: English
• Subjects: Amino Acids - analysis; Aminoquinolines - chemistry; Carbamates - chemistry; Chromatography, High Pressure Liquid - methods; Chromatography, Reverse-Phase - methods; Drugs, Generic - analysis; Drugs, Generic - chemistry; Gonadotropin-Releasing Hormone - analogs & derivatives; Gonadotropin-Releasing Hormone - analysis; Gonadotropin-Releasing Hormone - chemistry; Reproducibility of Results
• ISSN: 0021-9665; 1945-239X
• DOI: 10.1093/chromsci/bmaa030

Abstract Ganirelix is a synthetic decapeptide linked with nine different amino acids. To understand the peptide amino acid sequence or primary structure, the first step is to determine the amino acid composition of the peptide which can be a determining factor for the peptide immunogenicity. Edman degradation is not a suitable analytical technique to identify amino acid sequence present in Ganirelix due to the absence of uncharged N-terminal amino group. To address this challenge, a pre-column derivatization method was developed with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate reagent. In the present work, the Ganirelix active pharmaceutical ingredient present in the injectable formulation was isolated by fraction collection and further purified by flash chromatography. The amino acid composition of Ganirelix is assayed by carrying out acid hydrolysis with 6 mol L−1 hydrochloric acid solution containing 1% phenol at 100°C for 24 h and derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate reagent solution, followed by determination of individual amino acids by reverse-phase chromatography using a C18 column. High resolution was achieved for the nine amino acid mixture. The amino acid composition results of temperature-stressed Ganirelix generic product and reference listed drug are in good agreement with the theoretical molar ratio of label information.